Podcasts

Journal of Drugs in Dermatology (JDD)In this bonus edition of the JDD podcast, host Dr. Adam Friedman, Associate Professor of Dermatology and Residency Program Director at the GW School of Medicine and Health Sciences, discusses in detail the ins and outs of the most common benign cutaneous neoplasm: the seborrheic keratosis. Clinical presentations, diagnostic approaches, pearls, potential pitfalls, and a tornado of mostly off label treatment approaches - yea we got you. For the latest and greatest on managing these annoyingly common and bothersome lesions, press play.

Listen to Podcast >>


 

Journal of Drugs in Dermatology (JDD)In this edition of the JDD podcast, "Ask the Investigator," host Dr. Adam Friedman from the GW School of Medicine and Health Sciences is joined by internationally acclaimed hyperhidrosis expert and co-founder of the International Hyperhidrosis Society, Dr. David Pariser, to discuss his recent study entitled, "Understanding Patient Experience with Hyperhidrosis: A National Survey of 1,985 Patients" in the April 2018 edition of the JDD. Get inside the head of a hyperhidrosis sufferer to better approach and manage this disabiling medical condition. Hear from the best how to multimechanistically manage the meddling moisture. If you only listen to one podcast this year, listen to Serial (I hear it is great). But if you are going to listen to two, this is your answer. Listen to Podcast >>


 

Journal of Drugs in Dermatology (JDD)Join JDD Podcast host Dr. Adam Friedman from the GW SMHS and clinical trials guru Dr. Linda Stein Gold as they discuss the latest data on and practical experience with systemic agents for moderate to severe plaque psoriasis. How do they use them? Label vs off-label? Clinical considerations? Do I ask too many questions? Don't answer. Make sure to tune in to get the goods.

Listen to Podcast >>


 

Journal of Drugs in Dermatology (JDD)Back by popular demand, Dr. Steven Feldman, Professor of Dermatology, Pathology, and Public Health joins host Dr. Adam Friedman from GW School of Medicine to review his recent database dive entitled, "Trends in Atopic Dermatitis Management: Comparison of 1990-1997 to 2003-2012." What new trends, both good and bad, have emerged? What can we expect and hope for the future of AD care? What tricks of the trade do these two employ when utilizing systemic immunosuppressants? Itching for answers? Make sure to tune in.

Listen to Podcast >>

 


Journal of Drugs in Dermatology (JDD)In this throwback edition of the JDD Podcast "Ask the Investigator," host Dr. Adam Friedman speaks with Dr. Sylvia Hsu, Professor and Chair of Dermatology at the Lewis Katz School of Medicine at Temple University on her study published in the August 2008 edition of the JDD entitled, "A Case Series of 48 Patients Treated with Thalidomide." Get a taste of rich dermatology history with the evolution of thalidomide use in clinic practice. Hear how Dr. Hsu and colleagues undertook this case review and what they learned from their experiences. How does Dr. Hsu use Thalidomide in her practice today? Well, you will have to tune in to find out! 

Listen to Podcast >>

 


Journal of Drugs in Dermatology (JDD)In this month's JDD Podcast, Ask the Investigator, host Dr. Adam Friedman speaks with the trichology titan Dr. Jerry Shapiro, Professor of Dermatology at the NYU Langone Medical Center in NYC, on his recent cutting edge study published in the JDD entitled, "Novel Treatment Using Low-Dose Naltrexone for Lichen Planopilaris." Who, what, why how?? Exactly. Tune in to get your data fix and to inhale practical pearls from the master on this recalcitrant, scarring alopecia. Hitting rock bottm with LPP... not a chance with the JDD podcast. 

Listen to Podcast >>

 


Journal of Drugs in Dermatology (JDD)In this edition of the JDD podcast, Ask the Investigator, host Dr. Adam Friedman of GW School of Medicine and Health Sciences is joined by Albert Einstein College of Medicine Chief of Dermatology, Dr. Steven Cohen, for a throw back podcast covering his landmark 2016 JDD study entitled, "iPLEDGE Weakness: Is it Time to Address the Flaws?," which highlights the incomplete and inaccurate monitoring of the iPLEDGE program. Tune in to hear how this multicenter study identified a high percentage of inaccuracies with iPLEDGE patient monitoring. Have there been any changes since this manuscript hit the presses? How does a master medical dermatologist utilize it to counsel patients on isotretinoin use and side effects and push the envelope with both on and off label uses. Make sure to pop in on this one!

Listen to Podcast >>


Journal of Drugs in Dermatology (JDD)In this month's JDD Podcast, host Dr. Adam Friedman is joined by world renowned cosmetic dermatologist, Dr. Heidi Waldorf, Associate Clinical Professor of Dermatology at the Mt Sinai Health System in NYC to discuss her recent work in the September edition of the JDD entitled "First Consensus on Primary Prevention and Early Intervention in Aesthetic Medicine." Tune in to hear how 14 aesthetic experts joined forces to identify tailored approaches to prevent and reverse early signs of skin aging. Appreciate the limitations in the literature and the need for more research. Hear how the expert keeps her patients really, really, ridiculously good looking. Get your beauty sleep later - this is not to be missed. 

Listen to Podcast >>

 


Journal of Drugs in Dermatology (JDD)Join JDD Podcast host Dr. Adam Friedman in his deep dive of the newly developed and published global assessment of genital psoriasis entitled, "The Static Physician's Global Assessment of Genitalia: A Clinical Outcome Measure for the Severity of Genital Psoriasis" with senior author Dr. Joseph Merola, Director of the Center for Skin and Related Musculoskeletal Diseases and Assistant Professor of Dermatology and Rheumatology at Brigham and Women's Hospital. What stimulated this idea? How was this tool designed and validated? What does the expert recommend when evaluating and treating inflammatory diseases south of the border? Tune in to find out! 

Listen to Podcast >>

 


Journal of Drugs in Dermatology (JDD)In this edition of the JDD Podcast, Ask the Investigator, host Dr. Adam Friedman digs deep with UCSF Assistant Professor of Dermatology, Dr. Tina Bhutani, to powerlift the most up to date safety data on Class 1 superpotent topical steroids from her study entitled, "Update on the Systemic Risks of Superpotent Topical Steroids." Hear from the expert how to effectively use topical steroids while limiting local and systemic side effects, and how to get your patients on board, especially those nay sayers. Do not miss this clinically relevant and im-POTENT podcast (nailed it!).

Listen to Podcast >>

 


Journal of Drugs in Dermatology (JDD)In this eddition of the JDD Podcast, "Ask the Investigator," Dr. Adam Friedman sits down with Professor and Chair of Dermatology, Dr. Alison Ehrlich from GW SMHS to discuss her recent study in the June JDD entitled, "A Survey Assessment of US Dermatologists' Perception of Biosimliars." Simply put, biosimilars are not the same as generics... nor even their biologic counterparts. Do dermatologists on a whole see the light? Are biosimilars being welcomed with open arms or a quizzical brow? What regulations and expectations are already in place and what's to come? How does the director of the GW joint dermatology-rheumatology psoriasis clinic approach her patients, screen and monitor for co-morbidities, and select from the armament of systemic medications? Well you'll just have to tune in while sitting back, driving to work, or getting your work out on... it's all the (bio)same to us (see what I did there?). 

Listen to Podcast >>


Journal of Drugs in Dermatology (JDD)In this edition of the JDD Podcast, "Ask the Investigator," host Dr. Adam Friedman from GW School of Medicine welcomes back dermatology rock star Dr. Darrell Rigel to discuss his most recent study published in the May 2017 edition of the Journal of Drugs in Dermatology entitled, "Impact of a 31-gene Expression Profiling Test for Cutaneous Melanoma on Dermatologists' Clinical Management Decisions." See education in action as Dr. Rigel and colleagues demonstrate changes in dermatology resident management strategies for melanoma with the addition of a genetic profiling assay to the standard tumor grading tools. Can a fancy shmancy molecular marvel improve how we manage our patients and collaborate with other specialities? Can the 31-gene expression profiling test grant me three wishes? Tune in to find out. 

Listen to Podcast >>


Journal of Drugs in Dermatology (JDD)In this addition of the JDD Podcast, "Ask an Investigator," host Dr. Adam Friedman pulls out the goods with alopecia expert, Professor and Chairman of Dermatology at Wake Forest Baptist Health Dr. Amy McMIchael on her recent manuscript, "A Retrospective Review of Treatment Results for Patients with Central Centrifugal Cicatrical Alopecia." Tune in as we shed some light on which regimens work or don't work in order to gain some traction with your scarring alopecia patients. Word selection... purposeful.

Listen to Podcast >>


Journal of Drugs in Dermatology (JDD)In this special edition of the JDD podcast, with consideration from La Roche-Posay, host Dr. Adam Friedman is joined by acne guru Dr. Hilary Baldwin, Director of the Acne Research Center and Associate Professor of Dermatology at SUNY Downstate, to review the cutting edge of cutaneous microbiome research and translational applications. Yes you are covered in bacteria - accept it, own it, and love it. Learn how harmony between the >500 species on our skin keep our barrier and cutaneous immunity in check, and conversly, how dysbiosis can facilitate a broad range of cutaneous pathology. This special edition is not to be missed!

Listen to Podcast >>

 


Journal of Drugs in Dermatology (JDD)In this edition of the JDD Podcast, "Ask an Investigator," host Dr. Adam Friedman speaks with the Compliance King Dr. Steve Feldman on his recent study entitled "Treatment of Atopic Dermatitis in the United States: Analysis of Data from the National Ambulatory Medical Care Survey" highlighting the "Go Strong or Go Home" mentality of Dermatologists when treating atopic dermatitis as compared to primary care and pediatric physicians. Who uses what more, you may ask? Who falls for that hilarious FDA black box warning on calcineurin inhibitors the most? These questions and more will be answered so don't under listen!

Listen to Podcast >>

 


Journal of Drugs in Dermatology (JDD)In this edition of the JDD Podcast, "Ask an Investigator," host Dr. Adam Friedman speaks with Dr. Animesh Sinha, the Rita M. & Ralph T. Behling Professor and Chair of Dermatology at the SUNY Buffalo Jacobs School of Medicine and Biomedical Sciences, about his recent case study "Longitudinal Tracking of Autoantibody Levels in a Pemphigus Vulgaris Patient: Support for a Role of an Anti-Desmoglein 1 Autoantibodies as Predictors of Disease Progression." Whether you are trying to solidify your autoimmune blistering disease fund of knowledge or want to learn diagnostic and treatment tips from a vesicobullous victor, tune in to get the latest and most evidenced based juice on this family of disabling and life-threatening diseases.

Listen to Podcast >>

 


Journal of Drugs in Dermatology (JDD)In this edition of the JDD podcast "Ask the Investigator," host Dr. Adam Friedman from the GWU School of Medicine and Health Sciences interviews internationally recognized and NIH funded physician scientist Dr. Jared Jagdeo, Associate Professor of Dermatology at U.C. Davis, on his recent paper in the January 2017 edition of the JDD entitled, "A Systematic Review of Paradoxical Adipose Hyperplasia (PAH) Post-Cryolipollysis." Chow down on some practical pearls on conducting a systematic review, body conturing, addressing PAH, and then go back for seconds for a little innovation on using light based technologies to prevent scarring. Bon Apetit!

Listen to Podcast >>

 


Journal of Drugs in Dermatology (JDD)

In a galaxy far far forget.... not going to do it. In this month's edition of the JDD Podcast "Ask an Investigator" host Dr. Adam Friedman from the GW School of Medicine and Health Sciences teams up with laser surgeon extraordinaire Dr. Jill Waibel, Clinical Voluntary Professor at University of Miami and Clinical Assistant Professor of Dermatology for Wright State University, to discuss her latest study published in the November edition of the JDD, "The Diagnostic Role of Optical Coherence Tomography (OCT) in Measuring the Depth of Burn and Traumatic Scars for More Accurate Laser Dosimetry: Pilot Study." Discover how this novel non-invasive imaging system can further improve your ability to properly manage scars and what we can expect from it in the future. Learn the true power of laser surgery (and other stuff) from the yoda of laser surgery. Listen to this podcast, you must. 

Listen to Podcast >>


Journal of Drugs in Dermatology (JDD)

In this addition of the JDD Podcast: "Ask the Investigator" host, Dr. Adam Friedman, interviews Dr. Peter Lio, Clinical Assistant Professor in the Department of Dermatology and Pediatrics at Northwestern University, Feinberg School of Medicine, on his recent paper entitled "Therapeutic Synergy, Neutrality, and Antagonism: Combination Treatment in Dermatology." Tune in to hear where the evidence is strong, or lacking support, for the use of a wide array of combination therapies for different disease states. Get a taste for how Dr. Lio synergizes his approach with both allopathic and integrative medicine to improve patient outcomes. Monotherapy was so last year.

Listen to Podcast >>

 


Journal of Drugs in Dermatology (JDD)Join JDD podcast host Dr. Adam Friedman as he interviews the acclaimed and world renowned Dr. Darrel Rigel on his study published in the September Edition of the JDD entitled "Online Survey of US Dermatologists' Sunscreen Opinions: Perceptions, Recommendation Factors, and Self-Usage." Learn tips from the master on how to develop the best survey tool for maximum return, what gaps exist in the current photoprotection knowledge and practice amongst dermatologists, and importantly where and how we are doing things right. Not to be missed - get a first hand glimpse of how Dr. Rigel counsels his patients on photoprotective measures and associated controversies, as well as what's new with upcoming UV filter approvals, visible and near-infrared light, and polypodium leucotomos.

Listen to Podcast >>


Journal of Drugs in Dermatology (JDD)In this edition of the JDD Podcast, Dr. Adam Friedman reviews phototherapy protocols and pearls with psoriasis expert Dr. Jashin Wu, Director of Research at Kaiser Permanente based on his study published in the August 2016 Journal of Drugs in Dermatology titled "Comparison of Phototherapy Guidelines for Psoriasis: A Critical Appraisal and Comprehensive Review." Also tune in to hear how Dr. Wu counsels his psoriasis patients on psoriasis comorbidities and initiates, and manages them with phototherapy, topicals, and systemic immunosuppressants.

Listen to Podcast >>


Journal of Drugs in Dermatology (JDD)JDD Podcast host Dr. Adam Friedman gets first-hand insight from internationally acclaimed pediatric dermatologist Dr. Lawrence Eichenfield on his recent study entitled "Hormonal Contraceptives and Acne: A Retrospective Analysis of 2147 Patients" published in the June 2016 edition of the Journal of Drugs of Dermatology. Want a refresher on the use of OCPs in Acne? Interested in learning how to initiate a patient based survey study? Just curious how a leader in the field gets an uninterested adolescent to be compliant and engaged in his/her acne care? These are just a few of the practical pearls provided.

Listen to Podcast >>